ict01,pembrolizumab
merck,imcheck therapeutics
['ict01', 'pembro', 'eviction']
presents positive safety and efficacy data from the completed phase 1 dose escalation cohort of ict01 plus pembrolizumab in the eviction trial at esmo congress 2022 
We provide a balanced view on small cap biotech equities.